The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding and potential paralysis. The FDA said on Wednesday that healthcare professionals should carefully consider timing when inserting or removing a spinal catheter in patients taking Lovenox, which is made by Sanofi SA, or its generic versions, which are sold under the name enoxaparin. The catheters, fine plastic tubes, are used to deliver painkillers or anesthetics directly into the spine.
Help employers find you! Check out all the jobs and post your resume.
